(Finance) – Pharmacosma company listed on Euronext Growth Milan and active in the Health, Pharma & Beauty sector, closed on first semester of 2022 with revenues equal to 32.1 million euro, showing a growth of 22% compared to the same period of the previous year. The result, mainly linked to the growth of the B2C channel (+ 35% YoY), is all attributable to the organic growth of the pharmacosmo.it portal. L’EBITDA amounted to 238 thousand euros, up 39%. Not including the costs associated with the listing, EBITDA would be 478 thousand euros, up 178%. There net loss was 286 thousand euros, compared to a net loss of 212 thousand euros at 30 June 2021.
“We are very satisfied with the solid results achieved in the first half, the result of the strong organic growth of the pharmacosmo.it portal – commented theAD Fabio de Concilio – The results confirm the company among the leaders in the sector, confirming the solidity of the strategy pursued and the continuous growth trend “.
“We are working at the same time on the realization of the growth by external lines, in line with what was presented in the listing – he added – The agreement signed on 9 August for the acquisition of the majority stake in ProfumeriaWeb marks the entry into the luxury segment in the perfumery, cosmetics and make-up market. Further initiatives currently pursued intend to gradually create an integrated platform of services for care and well-being, consolidating growth in terms of customers, volumes and margins “.
There Net financial positionalready “cash positive” at the end of 2021 for € 0.8 million, stood at € 13.8 million “cash positive” (including proceeds from the IPO and net of related costs).
Regarding the outlook, Farmacosmo states that the second semester 2022 will feature the typical seasonality of the online commerce market, which recorded the main volumes in November and December. The last quarter of 2022 will also be characterized by the finalization of the agreement for the acquisition of the majority stake in ProfumeriaWeb.com.